JG
RVNC

Jefferies Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Jefferies Group’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,846
Closed -$30.1K – 2076
2021
Q4 		$30.1K Buy
+1,846
New +$30.8K ﹤0.01% 1540
2015
Q3 		– Sell
-173
Closed -$6K – 3211
2015
Q2 		$6K Buy
+173
New +$4.45K ﹤0.01% 2964
2015
Q1 		– Sell
-100,000
Closed -$1.69M – 2523
2014
Q4 		$1.69M Buy
+100,000
New +$1.75M 0.05% 775

Other funds holding RVNC

JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return